IT1169837B - Composizione farmaceutica utile per il miglioramento e/o il trattamento di sintomi mentali provocati da disturbi organici nel cervello - Google Patents

Composizione farmaceutica utile per il miglioramento e/o il trattamento di sintomi mentali provocati da disturbi organici nel cervello

Info

Publication number
IT1169837B
IT1169837B IT22949/83A IT2294983A IT1169837B IT 1169837 B IT1169837 B IT 1169837B IT 22949/83 A IT22949/83 A IT 22949/83A IT 2294983 A IT2294983 A IT 2294983A IT 1169837 B IT1169837 B IT 1169837B
Authority
IT
Italy
Prior art keywords
brain
improvement
treatment
pharmaceutical composition
composition useful
Prior art date
Application number
IT22949/83A
Other languages
English (en)
Italian (it)
Other versions
IT8322949A0 (it
Inventor
Shizuo Kuriyama
Saitoh Mikio
Original Assignee
Eisai Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eisai Co Ltd filed Critical Eisai Co Ltd
Publication of IT8322949A0 publication Critical patent/IT8322949A0/it
Application granted granted Critical
Publication of IT1169837B publication Critical patent/IT1169837B/it

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Neurosurgery (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Epidemiology (AREA)
  • Neurology (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
IT22949/83A 1982-09-22 1983-09-21 Composizione farmaceutica utile per il miglioramento e/o il trattamento di sintomi mentali provocati da disturbi organici nel cervello IT1169837B (it)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP57165546A JPS5955829A (ja) 1982-09-22 1982-09-22 脳内の器質性障害に起因する精神機能症状の改善・治療剤

Publications (2)

Publication Number Publication Date
IT8322949A0 IT8322949A0 (it) 1983-09-21
IT1169837B true IT1169837B (it) 1987-06-03

Family

ID=15814427

Family Applications (1)

Application Number Title Priority Date Filing Date
IT22949/83A IT1169837B (it) 1982-09-22 1983-09-21 Composizione farmaceutica utile per il miglioramento e/o il trattamento di sintomi mentali provocati da disturbi organici nel cervello

Country Status (5)

Country Link
US (2) US4507322A (https=)
EP (1) EP0103897B1 (https=)
JP (1) JPS5955829A (https=)
DE (1) DE3369640D1 (https=)
IT (1) IT1169837B (https=)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2506376B2 (ja) * 1987-07-16 1996-06-12 三菱化学株式会社 ２−（４−メチルアミノブトキシ）ジフェニルメタン・塩酸塩の製造方法
US5869536A (en) 1994-07-12 1999-02-09 Mitsubishi Chemical Corporation Treatment of hyperkinetic disorders
US5547993A (en) * 1995-10-24 1996-08-20 Mitsubishi Chemical Corporation Therapeutic agent for glaucoma

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE430156B (sv) * 1975-06-19 1983-10-24 Mitsubishi Chem Ind Sett att framstella 2-subst-1-(omega-aminoalkoxi)-bensener
JPS606349B2 (ja) * 1975-09-10 1985-02-18 三菱化成工業株式会社 ２―（ω‐アミノアルコキシ）ジフエニルメタン類

Also Published As

Publication number Publication date
JPH0233689B2 (https=) 1990-07-30
DE3369640D1 (en) 1987-03-12
IT8322949A0 (it) 1983-09-21
EP0103897A1 (en) 1984-03-28
US4507322A (en) 1985-03-26
EP0103897B1 (en) 1987-02-04
JPS5955829A (ja) 1984-03-31
US4576966A (en) 1986-03-18

Similar Documents

Publication Publication Date Title
ZA848369B (en) Pharmaceutical compositions containing bilobalid for the treatment of neuropathies
IT9020055A0 (it) Metodo per il mascheramento del sapore di farmaci
DK0713701T3 (da) 2-Brommelatonin til behandling af søvnforstyrrelser
ATE47035T1 (de) Kit oder vorrichtung und methode zum verabreichen von gangliosiden und deren derivate durch inhalation und dafuer geeignete pharmazeutische zusammensetzungen.
IT8548055A0 (it) Composizioni farmaceutiche per la terapia di sindromi cerebrali involutive e del decadimento mentale
IT1170728B (it) Dispositivo per la somministrazione di sostanze medicamentose
FI942400A7 (fi) Lääkeaine hermosairauksia vastaan
IT1169837B (it) Composizione farmaceutica utile per il miglioramento e/o il trattamento di sintomi mentali provocati da disturbi organici nel cervello
ES1022449Y (es) Aparato terapeutica para tratamiento de sintomas ocasionados por enfermedades.
DE3380923D1 (de) Pharmazeutische zusammensetzungen zur behandlung von stoerungen, bedingt durch humanendrogen.
FI874450A7 (fi) Farmaseuttiset valmisteet alkuperältään toiminnallisten ja elimelliste n aivohäiriöiden hoitamiseen.
DK468885D0 (da) Middel til topisk behandling af betaendelsestilstande i huden
IT1159815B (it) Composizione medicinale per il trattamento di certe neurovirosi
IT1143012B (it) Composti 6-aril pirimidinici per il trattamento e la prevenzione di infezioni virali e per stimolare la produzione di interferone
ES2054790T3 (es) Compuestos que tienen actividad cardiovascular.
IT8720034A0 (it) Composizioni farmaceutiche per il trattamento di sindromi psico-organiche cerebrali.
FR2575158B1 (fr) Arylalcoyloxymethyl-2 morpholines, leur preparation et leur application en tant que medicaments utiles dans le traitement des troubles du systeme nerveux central
ES526328A0 (es) Perfeccionamientos en dispositivos para el tratamiento de bandas continuas de genero
MX9307679A (es) Derivados de furanona utiles en terapia.
DK163245C (da) Middel til behandling af neurologiske forstyrrelser eller lidelser
IT8821369A0 (it) Composizione farmaceutica utile per il trattamento di malattie cardiovascolari.
ITMI931174A0 (it) Composizioni farmaceutiche per la cura della talassemia
IT1171692B (it) Preparato farmaceutico impiegabile per il trattamento della lebbra e/o di altre micobatteriosi
IT8422685A0 (it) Composizione farmaceutica eprocedimento per il trattamento di eccetazione psicomotoria.
ITMI930966A0 (it) Composizioni farmaceutiche per il trattamento della psoriasi

Legal Events

Date Code Title Description
TA Fee payment date (situation as of event date), data collected since 19931001

Effective date: 19970929